SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001178913-19-001996
Filing Date
2019-07-30
Accepted
2019-07-30 12:46:38
Documents
5
Period of Report
2019-07-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K zk1923326.htm 8-K 47192
2 EXHIBIT 5.1 exhibit_5-1.htm EX-5.1 9149
3 EXHIBIT 10.1 exhibit_10-1.htm EX-10.1 111429
4 EXHIBIT 99.1 exhibit_99-1.htm EX-99.1 16349
5 image0.jpg GRAPHIC 8283
  Complete submission text file 0001178913-19-001996.txt   197110
Mailing Address 2 HOLZMAN ST. WEIZMANN SCIENCE PARK REHOVOT L3 76704
Business Address 2 HOLZMAN ST. WEIZMANN SCIENCE PARK REHOVOT L3 76704 97289316233
Foamix Pharmaceuticals Ltd. (Filer) CIK: 0001606645 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36621 | Film No.: 19984232
SIC: 2833 Medicinal Chemicals & Botanical Products